| TERTIARY STRUCTURE DATA |
|
Homo sapiens
|
| NMR structure |
0.00 Å |
1F9X |
1F9X |
1F9X |
1F9X |
1F9X |
1F9X |
Sun et al., 2000 |
| mature inhibitor |
2.00 Å |
1G73 |
1G73 |
1G73 |
1G73 |
1G73 |
1G73 |
Wu et al., 2000 |
| mature inhibitor |
2.40 Å |
1I4O |
1I4O |
1I4O |
1I4O |
1I4O |
1I4O |
Huang et al., 2001 |
| complex with caspase-7 |
2.90 Å |
1KMC |
1KMC |
1KMC |
1KMC |
1KMC |
1KMC |
|
| mature inhibitor |
2.20 Å |
1OXN |
1OXN |
1OXN |
1OXN |
1OXN |
1OXN |
Franklin et al., 2003 |
| mature inhibitor |
2.30 Å |
1OXQ |
1OXQ |
1OXQ |
1OXQ |
1OXQ |
1OXQ |
Franklin et al., 2003 |
| mature inhibitor |
2.70 Å |
1OY7 |
1OY7 |
1OY7 |
1OY7 |
1OY7 |
1OY7 |
Franklin et al., 2003 |
| mature inhibitor |
0.00 Å |
1QBH |
1QBH |
1QBH |
1QBH |
1QBH |
1QBH |
Hinds et al., 1999 |
| mature inhibitor |
0.00 Å |
1TFQ |
1TFQ |
1TFQ |
1TFQ |
1TFQ |
1TFQ |
Oost et al., 2004 |
| mature inhibitor |
0.00 Å |
1TFT |
1TFT |
1TFT |
1TFT |
1TFT |
1TFT |
Oost et al., 2004 |
| ML-IAP/XIAP chimera; complex with a nonomer peptide derived from smac |
1.71 Å |
1TW6 |
1TW6 |
1TW6 |
1TW6 |
1TW6 |
1TW6 |
Vucic et al., 2005 |
| mature inhibitor |
0.00 Å |
2ECG |
2ECG |
2ECG |
2ECG |
2ECG |
2ECG |
|
| ML-IAP/XIAP chimera; complex with a tetramer peptide (Ala-Val-Pro-Trp) |
1.62 Å |
2I3H |
2I3H |
2I3H |
2I3H |
2I3H |
2I3H |
Zobel et al., 2006 |
| ML-IAP/XIAP chimera; complex with a peptidomimetic |
2.30 Å |
2I3I |
2I3I |
2I3I |
2I3I |
2I3I |
2I3I |
Zobel et al., 2006 |
| XIAP-BIR3 domain; complex with a SMAC-mimetic compound |
2.82 Å |
2JK7 |
2JK7 |
2JK7 |
2JK7 |
2JK7 |
2JK7 |
Sun et al., 2008 |
| mature inhibitor |
0.00 Å |
2KNA |
2KNA |
2KNA |
2KNA |
2KNA |
2KNA |
Hui et al., 2010 |
| mature inhibitor |
0.00 Å |
2L9M |
2L9M |
2L9M |
2L9M |
2L9M |
2L9M |
Lopez et al., 2011 |
| XIAP-BIR3 domain; complex with a SMAC-mimetic compound |
2.80 Å |
2OPY |
2OPY |
2OPY |
2OPY |
2OPY |
2OPY |
Wist et al., 2007 |
| XIAP-BIR3 domain; complex with AVPF |
3.00 Å |
2OPZ |
2OPZ |
2OPZ |
2OPZ |
2OPZ |
2OPZ |
Wist et al., 2007 |
| XIAP-BIR1 domain (i222 form) |
1.80 Å |
2POI |
2POI |
2POI |
2POI |
2POI |
2POI |
Lu et al., 2007 |
| complex with TAB1 |
3.10 Å |
2POP |
2POP |
2POP |
2POP |
2POP |
2POP |
Lu et al., 2007 |
| XIAP-BIR1 domain (p21 form) |
2.50 Å |
2QRA |
2QRA |
2QRA |
2QRA |
2QRA |
2QRA |
Lin et al., 2007 |
| XIAP-BIR3 domain; complex with a bivalent SMAC-mimetic compound |
2.10 Å |
2VSL |
2VSL |
2VSL |
2VSL |
2VSL |
2VSL |
Nikolovska-Coleska et al., 2008 |
| XIAP-BIR3 domain; complex with a SMAC-mimetic compound, smac005 |
2.70 Å |
3CLX |
3CLX |
3CLX |
3CLX |
3CLX |
3CLX |
Mastrangelo et al., 2008 |
| XIAP-BIR3 domain; complex with a SMAC-mimetic compound, smac010 ***caveat 3cm2 chirality errors at cb of thr j355 |
2.50 Å |
3CM2 |
3CM2 |
3CM2 |
3CM2 |
3CM2 |
3CM2 |
Mastrangelo et al., 2008 |
| XIAP-BIR3 domain; complex with SMAC-mimetic compound, SMAC005 |
3.10 Å |
3CM7 |
3CM7 |
3CM7 |
3CM7 |
3CM7 |
3CM7 |
Mastrangelo et al., 2008 |
| CIAP1-BIR3 domain; complex with N-terminal peptide from caspase-9 |
1.50 Å |
3D9T |
3D9T |
3D9T |
3D9T |
3D9T |
3D9T |
Kulathila et al., 2009 |
| CIAP1-BIR3 domain; complex with N-terminal peptide from smac/diablo (avpiaq). |
2.30 Å |
3D9U |
3D9U |
3D9U |
3D9U |
3D9U |
3D9U |
Kulathila et al., 2009 |
| mature inhibitor |
2.00 Å |
3EB5 |
3EB5 |
3EB5 |
3EB5 |
3EB5 |
3EB5 |
Mace et al., 2008 |
| mature inhibitor |
3.40 Å |
3EB6 |
3EB6 |
3EB6 |
3EB6 |
3EB6 |
3EB6 |
Mace et al., 2008 |
| XIAP-BIR3 domain; complex with a SMAC-mimetic compound |
3.00 Å |
3EYL |
3EYL |
3EYL |
3EYL |
3EYL |
3EYL |
Cossu et al., 2009 |
| ML-IAP/XIAP chimera; complex with a peptidomimetic |
1.80 Å |
3F7H |
3F7H |
3F7H |
3F7H |
3F7H |
3F7H |
Vucic et al., 2005 |
| ML-IAP/XIAP chimera; complex with a peptidomimetic |
1.90 Å |
3F7I |
3F7I |
3F7I |
3F7I |
3F7I |
3F7I |
Vucic et al., 2005 |
| XIAP-BIR3 domain; complex with a bivalent compound |
3.00 Å |
3G76 |
3G76 |
3G76 |
3G76 |
3G76 |
3G76 |
Cossu et al., 2009 |
| XIAP-BIR3 domain; complex with CS3 |
1.80 Å |
3HL5 |
3HL5 |
3HL5 |
3HL5 |
3HL5 |
3HL5 |
Ndubaku et al., 2009 |
| mature inhibitor |
2.61 Å |
3M0A |
3M0A |
3M0A |
3M0A |
3M0A |
3M0A |
Zheng et al., 2010 |
| mature inhibitor |
2.80 Å |
3M0D |
3M0D |
3M0D |
3M0D |
3M0D |
3M0D |
Zheng et al., 2010 |
| mature inhibitor |
2.00 Å |
3M1D |
3M1D |
3M1D |
3M1D |
3M1D |
3M1D |
Mace et al., 2010 |
| mature inhibitor |
2.60 Å |
3MUP |
3MUP |
3MUP |
3MUP |
3MUP |
3MUP |
Cossu et al., 2010 |
| mature inhibitor |
3.00 Å |
3OZ1 |
3OZ1 |
3OZ1 |
3OZ1 |
3OZ1 |
3OZ1 |
Cossu et al., 2010 |
| mature inhibitor |
1.90 Å |
3T6P |
3T6P |
3T6P |
3T6P |
3T6P |
3T6P |
Dueber et al., 2011 |
| mature inhibitor |
1.79 Å |
3UW4 |
3UW4 |
3UW4 |
3UW4 |
3UW4 |
3UW4 |
Flygare et al., 2012 |
| mature inhibitor |
1.79 Å |
3UW4 |
3UW4 |
3UW4 |
3UW4 |
3UW4 |
3UW4 |
Flygare et al., 2012 |
| mature inhibitor |
1.71 Å |
3UW5 |
3UW5 |
3UW5 |
3UW5 |
3UW5 |
3UW5 |
Flygare et al., 2012 |
| mature inhibitor |
2.60 Å |
4EB9 |
4EB9 |
4EB9 |
4EB9 |
4EB9 |
4EB9 |
Cossu et al., 2012 |
| mature inhibitor |
3.30 Å |
4EC4 |
4EC4 |
4EC4 |
4EC4 |
4EC4 |
4EC4 |
Cossu et al., 2012 |
| mature inhibitor |
2.84 Å |
4HY0 |
4HY0 |
4HY0 |
4HY0 |
4HY0 |
4HY0 |
Hashimoto et al., 2013 |
| mature inhibitor |
1.25 Å |
4HY4 |
4HY4 |
4HY4 |
4HY4 |
4HY4 |
4HY4 |
Hashimoto et al., 2013 |
| mature inhibitor |
1.75 Å |
4HY5 |
4HY5 |
4HY5 |
4HY5 |
4HY5 |
4HY5 |
Hashimoto et al., 2013 |
| mature inhibitor |
2.20 Å |
4IC2 |
4IC2 |
4IC2 |
4IC2 |
4IC2 |
4IC2 |
Nakatani et al., 2013 |
| mature inhibitor |
1.78 Å |
4IC3 |
4IC3 |
4IC3 |
4IC3 |
4IC3 |
4IC3 |
Nakatani et al., 2013 |
| mature inhibitor |
1.45 Å |
4J3Y |
4J3Y |
4J3Y |
4J3Y |
4J3Y |
4J3Y |
Lukacs et al., 2013 |
| mature inhibitor |
1.30 Å |
4J44 |
4J44 |
4J44 |
4J44 |
4J44 |
4J44 |
Lukacs et al., 2013 |
| mature inhibitor |
1.48 Å |
4J45 |
4J45 |
4J45 |
4J45 |
4J45 |
4J45 |
Lukacs et al., 2013 |
| mature inhibitor |
1.42 Å |
4J46 |
4J46 |
4J46 |
4J46 |
4J46 |
4J46 |
Lukacs et al., 2013 |
| mature inhibitor |
1.35 Å |
4J47 |
4J47 |
4J47 |
4J47 |
4J47 |
4J47 |
Lukacs et al., 2013 |
| mature inhibitor |
2.10 Å |
4J48 |
4J48 |
4J48 |
4J48 |
4J48 |
4J48 |
Lukacs et al., 2013 |
| mature inhibitor |
1.60 Å |
4KJU |
4KJU |
4KJU |
4KJU |
4KJU |
4KJU |
Kester et al., 2013 |
| mature inhibitor |
1.70 Å |
4KJV |
4KJV |
4KJV |
4KJV |
4KJV |
4KJV |
Kester et al., 2013 |
| mature inhibitor |
1.52 Å |
4KMN |
4KMN |
4KMN |
4KMN |
4KMN |
4KMN |
|
| mature inhibitor |
1.95 Å |
4KMP |
4KMP |
4KMP |
4KMP |
4KMP |
4KMP |
|
| mature inhibitor |
1.55 Å |
4LGE |
4LGE |
4LGE |
4LGE |
4LGE |
4LGE |
Asano et al., 2013 |
| mature inhibitor |
2.00 Å |
4LGU |
4LGU |
4LGU |
4LGU |
4LGU |
4LGU |
Asano et al., 2013 |
| mature inhibitor |
2.15 Å |
4MTI |
4MTI |
4MTI |
4MTI |
4MTI |
4MTI |
Shiokawa et al., 2013 |
| mature inhibitor |
2.10 Å |
4MTZ |
4MTZ |
4MTZ |
4MTZ |
4MTZ |
4MTZ |
|
| mature inhibitor |
1.79 Å |
4MU7 |
4MU7 |
4MU7 |
4MU7 |
4MU7 |
4MU7 |
Shiokawa et al., 2013 |
| mature inhibitor |
2.90 Å |
4OXC |
4OXC |
4OXC |
4OXC |
4OXC |
4OXC |
Cossu et al., 2015 |
| mature inhibitor |
2.09 Å |
4WVS |
4WVS |
4WVS |
4WVS |
4WVS |
4WVS |
Seigal et al., 2015 |
| mature inhibitor |
1.96 Å |
4WVT |
4WVT |
4WVT |
4WVT |
4WVT |
4WVT |
Seigal et al., 2015 |
| mature inhibitor |
2.02 Å |
4WVU |
4WVU |
4WVU |
4WVU |
4WVU |
4WVU |
Seigal et al., 2015 |
| mature inhibitor |
2.20 Å |
5C0K |
5C0K |
5C0K |
5C0K |
5C0K |
5C0K |
Chessari et al., 2015 |
| mature inhibitor |
2.60 Å |
5C0L |
5C0L |
5C0L |
5C0L |
5C0L |
5C0L |
Chessari et al., 2015 |
| mature inhibitor |
2.65 Å |
5C3H |
5C3H |
5C3H |
5C3H |
5C3H |
5C3H |
Chessari et al., 2015 |
| mature inhibitor |
2.02 Å |
5C3K |
5C3K |
5C3K |
5C3K |
5C3K |
5C3K |
Chessari et al., 2015 |
| mature inhibitor |
2.36 Å |
5C7A |
5C7A |
5C7A |
5C7A |
5C7A |
5C7A |
Chessari et al., 2015 |
| mature inhibitor |
2.68 Å |
5C7B |
5C7B |
5C7B |
5C7B |
5C7B |
5C7B |
Chessari et al., 2015 |
| mature inhibitor |
2.32 Å |
5C7C |
5C7C |
5C7C |
5C7C |
5C7C |
5C7C |
Chessari et al., 2015 |
| mature inhibitor |
2.25 Å |
5C7D |
5C7D |
5C7D |
5C7D |
5C7D |
5C7D |
Chessari et al., 2015 |
| mature inhibitor |
2.33 Å |
5C83 |
5C83 |
5C83 |
5C83 |
5C83 |
5C83 |
Chessari et al., 2015 |
| mature inhibitor |
2.36 Å |
5C84 |
5C84 |
5C84 |
5C84 |
5C84 |
5C84 |
Chessari et al., 2015 |
| small molecule inhibitors of iap |
2.32 Å |
5M6E |
5M6E |
5M6E |
5M6E |
5M6E |
5M6E |
|
| small molecule inhibitors of iap |
2.39 Å |
5M6F |
5M6F |
5M6F |
5M6F |
5M6F |
5M6F |
|
| small molecule inhibitors of iap |
2.50 Å |
5M6H |
5M6H |
5M6H |
5M6H |
5M6H |
5M6H |
|
| small molecule inhibitors of iap |
2.61 Å |
5M6L |
5M6L |
5M6L |
5M6L |
5M6L |
5M6L |
|
| small molecule inhibitors of iap |
2.37 Å |
5M6M |
5M6M |
5M6M |
5M6M |
5M6M |
5M6M |
|
| small molecule inhibitors of iap |
1.80 Å |
5M6N |
5M6N |
5M6N |
5M6N |
5M6N |
5M6N |
|
| xiap in complex with small molecule |
2.31 Å |
5OQW |
5OQW |
5OQW |
5OQW |
5OQW |
5OQW |
|
| crystal structure of ciap1-bir3 in complex with a covalently bound sm |
2.20 Å |
6EXW |
6EXW |
6EXW |
6EXW |
6EXW |
6EXW |
|
| crystal structure of xiap-bir3 in complex with a ciap1-selective sm |
2.70 Å |
6EY2 |
6EY2 |
6EY2 |
6EY2 |
6EY2 |
6EY2 |
|
| structure of xiap-bir1 domain in complex with an nf023 analog |
1.90 Å |
6GJW |
6GJW |
6GJW |
6GJW |
6GJW |
6GJW |
|
| fragment derived xiap inhibitor |
2.63 Å |
6H6Q |
6H6Q |
6H6Q |
6H6Q |
6H6Q |
6H6Q |
|
| fragment derived xiap inhibitor |
2.03 Å |
6H6R |
6H6R |
6H6R |
6H6R |
6H6R |
6H6R |
|
| structure of xiap-bir1 v86e mutant |
2.30 Å |
6QCI |
6QCI |
6QCI |
6QCI |
6QCI |
6QCI |
|